New injection could transform life for bleeding disorder patients
Disease control
Recruiting now
This study is testing whether a new injection called VGA039 can safely prevent bleeding episodes in people with von Willebrand disease, a genetic bleeding disorder. The trial will follow 60 patients aged 12-75 who experience frequent bleeding episodes. Participants will first be …
Phase: PHASE3 • Sponsor: Vega Therapeutics, Inc • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC